GLP-1 Era Redefines Formulation: Focus Shifts to Protein, Hydration, and Fortification

The proliferation of GLP-1 (Glucagon-Like Peptide-1) medications is driving a profound shift in consumer dietary preferences, presenting both challenges and opportunities for supplement manufacturers and brand owners. As GLP-1 use becomes more widespread, particularly across Europe, patients are adopting healthier eating habits, placing new demands on food and supplement formulations, as highlighted by Jungbunzlauer's upcoming webinar insights. Key areas of impact include increased demand for protein, reduced sugar and calorie content, and enhanced mineral and vitamin fortification.

Manufacturers must address the dual challenge of reformulating products to meet these evolving needs while maintaining product appeal. Reducing sugar and calorie intake is paramount for GLP-1 users, yet achieving this without compromising texture and flavour requires sophisticated ingredient solutions and process innovation. Jungbunzlauer's Market Development Manager for Europe & APAC, Thomas Bernsmeier, notes that the initial dietary shifts are significant, with a clear focus on calorie and sugar reduction for long-term weight management.

Innovation is increasingly concentrating on specific product formats. Beverages, including rehydration products and vitamin-enriched waters, are emerging as a major growth area. Similarly, the supplement sector is seeing a rise in fortified gummies. This trend suggests a strategic pivot towards convenient, palatable delivery systems that can incorporate essential nutrients. While no formal 'GLP-1-friendly' food definition exists, consumers are leveraging existing nutritional labelling systems, such as Nutri-Score, to inform their purchasing decisions. Companies like Jungbunzlauer are actively developing ingredient concepts, such as sugar substitutes and mineral fortification, to support manufacturers in navigating these new formulation requirements.

What this means for United Kingdom

UK supplement manufacturers face immediate pressure to assess current product portfolios against evolving GLP-1 user needs, especially for protein, electrolyte, and vitamin D supplements. Compliance with UK Food Standards Agency (FSA) guidance on nutrient claims for reformulated products will be critical, requiring careful dossier preparation. Brand owners should anticipate increased consumer scrutiny of 'healthy' claims, necessitating robust scientific substantiation beyond marketing rhetoric. Reformulation windows for key product lines should be aggressive, targeting Q3 2025 launches to capture early market share. Procurement teams must secure reliable supply chains for functional ingredients like advanced protein isolates, non-nutritive sweeteners, and bioavailable mineral forms to mitigate lead time risks and manage potential cost increases.

The emphasis on sugar and calorie reduction will inevitably impact ingredient procurement strategies. Manufacturers should anticipate increased demand for bulk suppliers of low-calorie sweeteners and texture enhancers, potentially affecting pricing and lead times for these components. Furthermore, the push for fortification with vitamins and minerals, especially in beverages and gummies, signals a need for robust quality control and regulatory adherence to ensure claim substantiation and product stability. Companies failing to adapt swiftly risk market share erosion to agile competitors who can meet these new consumer demands.

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.